化学抗原受体T细胞用于治疗多发性骨髓瘤
Ugo Testa1, Elvira Pelosi1, Germana Castelli1
1Departmet of Oncology, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
Mediterranean journal of hematology and infectious diseases
|November 13, 2024
概括
化学抗原受体T (CAR-T) 细胞疗法对多发性骨髓瘤 (MM) 治疗具有前景,但患者反应和复发等挑战仍然存在. 研究正在探索早期的MM治疗阶段和新的CAR-T目标.
科学领域:
- 血液学 血液学 血液学
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 是一种无法治愈的血细胞恶性瘤.
- 免疫疗法,包括CAR-T细胞,提供有效的MM治疗选择.
- 抗BCMA CAR-T 细胞已被批准用于复发性/耐药性MM.
研究的目的:
- 审查多发性骨髓瘤中CAR-T细胞治疗的疗效和局限性.
- 讨论正在进行的研究以及MM中CAR-T细胞应用的未来方向.
主要方法:
- 对多发性骨髓瘤免疫疗法策略的文献综述.
- 对MM患者的CAR-T细胞治疗临床试验数据的分析.
- 检查MM中CAR-T细胞治疗的挑战和未来前景.
主要成果:
- 抗BCMA CAR-T 细胞显著影响了复发性/耐药性MM治疗.
- 限制包括患者的可变反应,复发,成本和先前的抗BCMA暴露.
- 目前正在进行的试验调查了早期的MM治疗和替代的CAR-T标.
结论:
- 卡尔-T细胞疗法代表了多发性骨髓瘤治疗的重大进步.
- 解决目前的局限性对于改善患者的治疗结果至关重要.
- 未来的研究重点是优化CAR-T细胞疗法以获得更广泛的MM适用性.
相关概念视频
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K